DRG International, Inc. is a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for Immunoassays and Clinical Chemistry. Founded in 1970, DRG International, Inc. provides a complete range of products and services to the diagnostic and research communities. DRG International’s global headquarters is conveniently situated in Springfield, New Jersey. Only 20 miles from New York City and 80 miles from Philadelphia, PA; DRG International, Inc. is in the heart of the Tri-State Area.
Quality – DRG International, Inc. operates in accordance with the FDA 21 CFR 820 Quality System Regulation as well as the ISO 13485:2016 standard. DRG maintains certifications in both ISO 13485:2016 and MDSAP (Medical Device Single Audit Program) by TÜV Rheinland.
Sales – The majority of DRG sales are in immunodiagnostics worldwide, however, DRG is also an authorized distributor of CHROMagar chromogenic medium within the United States. With our recent MDSAP certification, as well as over 200 FDA approved products and over 75 products registered with Health Canada, we are looking to expand our reach throughout North America and globally. Strong markets for DRG products are throughout Europe, Poland, Russia, the US, the Middle East, Asia- Pacific, China, and South America.
Employees – DRG International employs approximately 120 people worldwide. We have a multi-lingual, multicultural sales and service team ready to serve you.
Founder – Dr. Cyril E. Geacintov (1930-2017)
President & CEO – Mrs. Elke Geacintov
DRG® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic devices. Founded in 1970, DRG International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products worldwide.
Click a location on the map below to receive more information about the selected office.
| Title | Address | Description |
|---|---|---|
UNITED STATES | 841 Mountain Ave, Springfield Township, NJ 07081, USA | DRG International, Inc. Global Headquarters Tel: +1-973-564-7555 |
GERMANY | Frauenbergstraße 18, 35039 Marburg, Germany | DRG Instruments GmbH, R&D and Production Tel: +49 (0)-6421/1700-0 |
RUSSIA - Moscow | Moscow, Russia, 117218 | DRG Techsystems, ZAO Tel: +7 (499)-277-07-20 |
RUSSIA - St. Petersburg | St Petersburg, Russia, 194156 | DRG Biomed, OOO Tel: +7 (812)-492-5693/492-5793 |
POLAND | Wita Stwosza 24, 02-661 Warszawa, Poland | DRG MEDTEK Tel: +48-(22)-847-82-44/83-75 |
CZECH REPUBLIC | Šumavská 33, 602 00 Brno-střed, Czechia | DRG Spol. S.R.O. Tel/Fax: +00420-532-091-339 |
CROATIA | Ul. Antuna Bauera 19, 10000, Zagreb, Croatia | DRG Croatia, Rep. Office Tel/Fax: + 38-(51)-462-10-87 |
Philanthropic/Board Memberships
News and Updates
HYBRiD Hepcidin Wins in Paris!
This past week, hundreds gathered for the JIB 2019 - Days of Innovation in Medical Biology 2019, the largest lab congress in France. This annual convention took place at the beautiful l’Espace Grand Arche, Paris-La Défense. Over 2 days the JIB hosted a succession of...
DRG International Exhibiting at ASH Annual Meeting 2019 – Booth #764
DRG International, Inc. is proud to be a featured participant at the ASH Annual Meeting and Exposition 2019 held in Orlando, FL December 7 - 10, 2019! Please visit the DRG booth #764 to learn more about our products, including our Hepcidin 25-bioactive HS ELISA,...
DRG:HYBRiD-XL® Summer Workshop Recap
On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...
